Biofarm S.A.

BIO

ROBIOFACNOR9

Pharmaceuticals

End-of-day quote Bucharest S.E. Other stock markets 23:00:00 01/07/2024 BST			5-day change	1st Jan Change
0.798 ^RON	0.00%		-0.25%	-3.16%

05-14	Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-28	Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Biofarm S A : 2024 06 28 Current Report

June 28, 2024 at 03:27 pm

cod JA-F002-rev01

Translation from Romanian

Biofarm output number: 267/28.06.2024

CURRENT REPORT

according to the F.S.A. Regulation No. 5/2018

Date of the report: 28.06.2024

Name of the Commercial company: BIOFARM S.A.

Registered office: Bucharest, str. Logofatul Tautu, nr. 99, sector 3

Telephone No.: 021/301.06.87

Fax No.: 021/316.52.48

Website: www.biofarm.ro

Unique registration code: RO 341563

Order No. with the Trade Register: J40/199/1991

Fully paid-up share capital: lei 98,537,535

Market on which company securities are traded - Bucharest Stock Exchange, BIO symbol

Important event to report:

Dispute in which the company is involved

The Board of Directors of BIOFARM S.A. informs the shareholders regarding the dispute below with hearing in June 2024:

	FILE NO.	PARTIES	COURT	STAGE	OBJECT	REMARKS	CURRENT TRIAL DATE	NEXT TRIAL
									DATE

2	17619/3/2015	A&G	Med	Court of Law	Merits	Insolvency	Biofarm S.A. is registered in the	At the trial term of 27.06.2024 the	21-11-2024
		Trading	S.R.L.-	of Bucharest		debtor's list of creditors with the	court ordered the postponement of
			proceedings
		Debtor		Municipality		amount of lei 10,507,522.28 lei,	the case for 21.11.2024 for the

							being an unsecured creditor.	continuation of the procedure, in
		Biofarm -					order to recover the claims.
		Creditor

B.D. CHAIRMAN

HREBENCIUC Andrei

99 Logofătul Tăutu Street, District 3, Bucharest, Romania, 031212

T: +40 21 301 0600; F: +40 21 301 0605; Email: office@biofarm.ro; biofarm.ro

Share capital 98.537.535 lei, fully subscribed and paid-up, RO341563, J40/199/5.02.1991

Account RO26 BRDE 441 SV 28095 174410, BRD Unirii Branch

Attachments

Original Link
Original Document
Permalink

Disclaimer

BIOFARM SA published this content on 28 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2024 14:26:22 UTC.

Latest news about Biofarm S.A.

Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-14	CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	10/08/23	CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23	CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23/02/23	CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	13/11/22	CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	11/08/22	CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	12/05/22	CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	24/02/22	CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021	14/11/21	CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	12/08/21	CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	14/05/21	CI
Biofarm S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	14/02/21	CI
Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2020	12/11/20	CI
Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	13/08/20	CI
Biofarm S.A. Announces Dividend for 2019, Payable on September 3, 2020	09/08/20	CI
Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2020	14/05/20	CI
Biofarm Reports Earnings Results for the First Quarter of 2016	17/05/16	CI
S.C. Biofarm S. A. Reports Sales Results for the First Quarter of 2016	11/05/16	CI
Biofarm Reports Earnings Results for the Year 2015	17/02/16	CI
Biofarm Reports Earnings Results for the First Quarter of 2015	15/05/15	CI
Biofarm Announces Earnings Results for the First Nine Months of 2014	17/11/14	CI
Tranche Update on BioFarm SA's Equity Buyback Plan announced on April 18, 2014.	17/09/14	CI
BioFarm SA's Equity Buyback announced on April 18, 2014, has closed with 109,486,149 shares, representing 10% for RON 33.4 million.	15/09/14	CI

Chart Biofarm S.A.

Duration

Period

More charts

Company Profile

Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Companyâs product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.

Sector

Pharmaceuticals

Calendar

19/08/2024 - Détachement de for final dividend

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BIOFARM S.A.	-3.16%	170M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.80%	43.81B
OTSUKA HOLDINGS CO., LTD.	+30.40%	23.03B
SANDOZ GROUP AG	+21.32%	15.45B
CIPLA LIMITED	+19.05%	14.4B
ZYDUS LIFESCIENCES LIMITED	+58.92%	12.95B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.84%	6.49B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.00%	5.49B